Brief: Epigenomics Says EVP Of Finance Albert Weber Leaves Co
07/10/2021 07:05
Oct 7 (Reuters) - EPIGENOMICS AG ECXn.DE :
* EVP OF FINANCE ALBERT WEBER LEAVES COMPANY
* COMPANY HAS INITIATED SEARCH FOR HIS SUCCESSOR.
* ALBERT WEBER WILL REMAIN AVAILABLE TO COMPANY IN AN
ADVISORY
CAPACITY UNTIL JUNE 30, 2022. COMPANY HAS INITIATED SEARCH FOR
HIS SUCCESSOR.
* ALBERT WEBER WILL RESIGN FROM HIS POSITION AS MEMBER OF
EXECUTIVE BOARD OF EPIGENOMICS AG AS OF DECEMBER 31, 2021, TO
PURSUE OTHER INTERESTS.
Source text for Eikon: ID:nEQ7Cdfcda
Further company coverage: ECXn.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns